Evidence map›Paper›PMID 28290502›Full record

ArticleScientific reports2017

Extracellular matrix and α

Nunzia Di Maggio, Elisa Martella, Agne Frismantiene, Therese J Resink, Simone Schreiner, Enrico Lucarelli, Claude Jaquiery, Dirk J Schaefer, Ivan Martin, Arnaud Scherberich

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Role and mechanism of Integrin α5β1 in bone formation and disease.Frontiers in cell and developmental biology · 2025
    Review
  2. Targeting integrin pathways: mechanisms and advances in therapy.Signal transduction and targeted therapy · 2023
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Screening of integrins localized on the surface of human epidermal melanocytes.In vitro cellular & developmental biology. Animal · 2020
    Article
  12. Article
  13. The Roles of Integrin α5β1 in Human Cancer.OncoTargets and therapy · 2020
    Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Nunzia Di MaggioLaboratory of Tissue Engineering, Department of Surgery, University Hospital of Basel and Department of Biomedicine, University of Basel, Switzerland.
Elisa MartellaOsteoarticular Regeneration Laboratory, Istituto Ortopedico Rizzoli, Bologna, Italy.
Agne FrismantieneLaboratory of Signal Transduction, Department of Biomedicine, University Hospital Basel, Basel, Switzerland.
Therese J ResinkLaboratory of Signal Transduction, Department of Biomedicine, University Hospital Basel, Basel, Switzerland.
Simone SchreinerLaboratory of Tissue Engineering, Department of Surgery, University Hospital of Basel and Department of Biomedicine, University of Basel, Switzerland.
Enrico LucarelliOsteoarticular Regeneration Laboratory, Istituto Ortopedico Rizzoli, Bologna, Italy.
Claude JaquieryClinic for Oral and Maxillofacial Surgery, University Hospital of Basel, Basel, Switzerland.
Dirk J SchaeferDepartment of Plastic, Reconstructive, Aesthetic and Hand Surgery, University Hospital of Basel, Switzerland.
Ivan MartinLaboratory of Tissue Engineering, Department of Surgery, University Hospital of Basel and Department of Biomedicine, University of Basel, Switzerland.
Arnaud ScherberichLaboratory of Tissue Engineering, Department of Surgery, University Hospital of Basel and Department of Biomedicine, University of Basel, Switzerland.
University Hospital of Basel · CHUniversity of Basel · CHUniversity of Bologna · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stromal vascular fraction (SVF) cells of human adipose tissue have the capacity to generate osteogenic grafts with intrinsic vasculogenic properties. However, adipose-derived stromal/stem cells (ASC), even after minimal monolayer expansion, display poor osteogenic capacity in vivo. We investigated whether ASC bone-forming capacity may be maintained by culture within a self-produced extracellular matrix (ECM) that recapitulates the native environment. SVF cells expanded without passaging up to 28 days (Unpass-ASC) deposited a fibronectin-rich extracellular matrix and displayed greater clonogenicity and differentiation potential in vitro compared to ASC expanded only for 6 days (P0-ASC) or for 28 days with regular passaging (Pass-ASC). When implanted subcutaneously, Unpass-ASC produced bone tissue similarly to SVF cells, in contrast to P0- and Pass-ASC, which mainly formed fibrous tissue. Interestingly, clonogenic progenitors from native SVF and Unpass-ASC expressed low levels of the fibronectin receptor α

Indexed as

AdipocytesAdipose TissueAnimalsBone and BonesBone DevelopmentCell Culture TechniquesCell DifferentiationExtracellular MatrixFibronectinsHumansIntegrin alpha5beta1MiceOsteogenesisSignal TransductionStem CellsStromal CellsFibronectinsIntegrin alpha5beta1

Identifiers

PMID28290502
PMCPMC5349595
OpenAlexW2625420932

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.